CME Group (NASDAQ:CME) Stock Rating Reaffirmed by Royal Bank of Canada

CME Group (NASDAQ:CME)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank of Canada in a report issued on Thursday, Benzinga reports. They currently have a $235.00 price target on the financial services provider’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of 3.88% from the company’s current price.

Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. lifted their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Bank of America lifted their target price on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, Barclays lifted their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $212.77.

CME Group Trading Up 1.2 %

Shares of CME stock traded up $2.66 on Thursday, reaching $226.23. 391,556 shares of the company’s stock were exchanged, compared to its average volume of 1,954,055. CME Group has a 52 week low of $190.70 and a 52 week high of $226.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $81.46 billion, a PE ratio of 25.67, a P/E/G ratio of 8.74 and a beta of 0.55. The company’s fifty day simple moving average is $211.20 and its 200 day simple moving average is $207.59.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the company earned $2.30 EPS. CME Group’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, analysts forecast that CME Group will post 9.94 EPS for the current year.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

A number of hedge funds have recently modified their holdings of the stock. B. Riley Wealth Advisors Inc. boosted its stake in shares of CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC raised its holdings in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC raised its holdings in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares during the period. Lester Murray Antman dba SimplyRich raised its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares during the period. Finally, Greystone Financial Group LLC raised its holdings in CME Group by 1.6% in the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after purchasing an additional 52 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.